1.Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery.
Ting DENG ; Yanling FENG ; Junsheng ZHENG ; Qidan HUANG ; Jihong LIU
Journal of Gynecologic Oncology 2015;26(2):111-117
OBJECTIVE: To evaluate the prognostic implication of human papillomavirus (HPV) viral load in cervical cancer patients who underwent radical hysterectomy. METHODS: We conducted a retrospective review of patients with stage IA2 through stage IIIA cervical carcinoma who underwent radical hysterectomy at Sun Yat-sen University Cancer Center between January 2005 and December 2009. Patients who had undergone preoperative hybrid capture 2 testing to detect HPV DNA were included. A total of 346 patients positive for HPV DNA were enrolled and stratified into two groups according to the median HPV viral load. RESULTS: HPV viral load was significantly correlated with lymphovascular space invasion (p=0.026) and deep stromal invasion (p=0.024). However, other factors, such as age, stage, histologic grade, histologic type, lymph node metastasis, and tumor size, were not significantly associated with viral load. Low HPV viral load was correlated with poor disease-free survival in univariate analysis (p=0.037) and multivariate analysis (p=0.027). There was no significant difference in overall survival with regard to initial HPV viral load. CONCLUSION: Low initial HPV viral load may be a poor prognostic factor for cervical cancer patients who have undergone radical hysterectomy.
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Squamous Cell/*diagnosis/surgery/virology
;
Female
;
Humans
;
Middle Aged
;
Papillomaviridae/*isolation & purification
;
Papillomavirus Infections/complications/diagnosis/surgery/virology
;
Prognosis
;
Retrospective Studies
;
Treatment Outcome
;
Uterine Cervical Neoplasms/*diagnosis/surgery/virology
;
*Viral Load
;
Young Adult
2.Clinical features and treatment of cervical malignant tumor in young women.
Yu ZHANG ; Keng SHEN ; Jin-song GAO ; Ming WU ; Hui-fang HUANG ; Ling-ya PAN ; Jing-he LANG
Acta Academiae Medicinae Sinicae 2003;25(4):391-395
OBJECTIVETo evaluate clinical characteristics, prognosis, prognostic factors, and the ideal treatment of the young patients with cervical malignant tumor.
METHODSWe analyzed retrospectively 52 cervical malignant tumor patients younger than 35 years (study group) and 45 cervical carcinoma patients older than 50 years (control group) who were admitted in Peking Union Medical College Hospital from 1985 to 2002. The data were analyzed statistically by SPSS10.0. The ovarian functions were evaluated by the questionnaire and the serum sex hormone assay.
RESULTSIn study group, the median age was (31.0 +/- 0.6) years old. The most common clinical symptoms were contact bleeding and irregular bleeding; 55.8% of patients had more than one symptom. HPV positive rate was 20.5%, which was higher than control group significantly (P < 0.05). The percentage of advanced stage (stage II b-stage IV b) of disease in study group and control group were 30.8% and 22.2%, respectively, the difference was significant (P < 0.05). The most common histological type was squamous cell carcinoma (71.2%) in study group, while the percentage of non-squamous cell carcinoma (43.8%) in patients younger than 30 years was much higher than control group (P < 0.05). All the histological type was non-squamous cell carcinoma in the patients younger than 25 years. Histological grade showed that G1, G2, and G3 were 21.2%, 54.5%, and 24.2% respectively in study group. The percentage of bulky cervix (tumor diameter > 4 cm) in study group and control group was 27.9% and 2.7% respectively (P < 0.005). The overall 5-year survival rates were 75.7% in study group, lower than control group (P < 0.05). The COX hazards regression model showed histological type (P = 0.003) and bulky cervix (P = 0.001) were of significant prognostic values.
CONCLUSIONSThere are more advanced stage carcinoma and non-squamous cell carcinoma patients with poor prognosis in study group. The treatment to younger patients should be concerned individually, as well as preservation of reproductive and female endocrine function should be considered.
Adenocarcinoma ; diagnosis ; surgery ; virology ; Adult ; Age Factors ; Carcinoma, Squamous Cell ; diagnosis ; surgery ; virology ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Ovarian Function Tests ; Papillomaviridae ; isolation & purification ; Papillomavirus Infections ; Prognosis ; Regression Analysis ; Retrospective Studies ; Survival Rate ; Uterine Cervical Neoplasms ; diagnosis ; surgery ; virology
3.Clinicopathologic study of 24 patients with vulvar intraepithelial neoplasia III.
Hua LI ; Wen-hua ZHANG ; Ling-ying WU ; Rong ZNANG ; Ping BAI
Chinese Journal of Oncology 2005;27(5):306-308
OBJECTIVETo review the diagnosis methods and treatment modalities of vulvar intraepithelial neoplasia III (VINIII) and to analyse its prognostic factors.
METHODSThe data of 24 patients with VINIII from 1992 to 2002 were retrospectively reviewed and analysed.
RESULTSAmong these 24 patients, 62.5% (15 patients) were aged less than 40 years and 37.5% (9 patients) over 40 years. Human papillomavirus (HPV) infection was found in 53.3% and 2/9 of these two groups. Treatment modality for all patients was surgical excision including extended local excision (33.3%) and simple vulvectomy (66.7%). 3 patients (12.5%) developed recurrence. Positive resection margin was correlated with recurrence, while age, HPV infection, multifocality and resection modality were not.
CONCLUSIONDuring recent years, the incidence of VIN has been on the increase in younger woman patients which maybe due to the increase of HPV infection, and the data show that the recurrence rate is correlated with positive margin. Treatment should be individualized and either extended local excision or simple vulvectomy is appropriate. Periodical follow-up should be done.
Adult ; Aged ; Carcinoma in Situ ; diagnosis ; surgery ; virology ; China ; epidemiology ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasms, Squamous Cell ; diagnosis ; surgery ; virology ; Papillomaviridae ; Papillomavirus Infections ; epidemiology ; Prognosis ; Retrospective Studies ; Vulvar Neoplasms ; diagnosis ; surgery ; virology
4.Detecting plasma Epstein-Barr virus DNA to diagnose postradiation nasopharyngeal skull base lesions in nasopharyngeal carcinoma patients: a prospective study.
Fa-Ya LIANG ; Wei SUN ; Ping HAN ; Xing LU ; Ying-Ni LIAN ; Xiao-Ming HUANG
Chinese Journal of Cancer 2012;31(3):142-149
The diagnosis of postradiation nasopharyngeal skull base lesions in petients with nasopharyngeal carcinoma (NPC) is still a tough problem in clinical practice. An early and accurate diagnosis is important for subsequent management. We prospectively evaluated the diagnostic value of plasma Epstein-Barr virus(EBV) DNA in detecting postradiation nasopharyngeal skull base lesions in NPC patients. From July 2006 to September 2010, 90 patients with postradiation NPC (34 women and 56 men; median age: 42 years) met the selection criteria and were recruited in this study. All postradiation nasopharyngeal skull base lesions were found in the latest magnetic resonance imaging (MRI) examinations before endoscopic surgery, and the nasopharyngeal cavity was normal under flexible nasopharyngoscopy. Plasma EBV DNA detection was performed within 2 weeks before endoscopic surgery. A total of 90 endoscopic operations were successfully performed without any postoperative complications. Recurrences confirmed by postoperative pathology were found in 30 patients. The specificity, positive and negative predictive values of plasma EBV DNA detection were better than those of MRI. In addition, combining plasma EBV DNA detection with MRI improved the specificity and positive predictive values of MRI. Plasma EBV DNA detection followed by MRI would help to diagnose recurrence whereas MRI was unable. These results indicate that plasma EBV DNA is an effective and feasible biomarker for detecting postradiation nasopharyngeal skull base lesions in NPC patients.
Adult
;
Carcinoma, Squamous Cell
;
blood
;
radiotherapy
;
virology
;
DNA, Viral
;
blood
;
Endoscopy
;
Female
;
Follow-Up Studies
;
Herpesvirus 4, Human
;
genetics
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Nasopharyngeal Neoplasms
;
blood
;
radiotherapy
;
virology
;
Nasopharynx
;
pathology
;
Neoplasm Recurrence, Local
;
diagnosis
;
virology
;
Neoplasm, Residual
;
Osteoradionecrosis
;
diagnosis
;
surgery
;
Prospective Studies
;
Skull Base
;
pathology